Robert Smith listens as Dr. Vladimir Berthaud speaks with Black patients about participating in clinical trials for a COVID-19 vaccine candidate./Blake Farmer for KHN
So far, participation by minority volunteers in coronavirus trials has increased only slightly compared with the usually low levels in other clinical trials.
The Food and Drug Administration is weighing whether to resume a coronavirus vaccine trial that was halted when a volunteer suffered spinal cord damage as federal health officials launch an investigation.
An annual event by CCO Oregon drew key players, who discussed the challenges of plunging revenues, ensuring access to a vaccine when one is available and adapting to the changing health care landscape.
Sep 9, 2020
Premium
Image
Mardell Reed volunteers for Advocates for African American Elders in Pasadena, California, a group that helps Blacks with health issues.Heidi di Marco/Kaiser Health News
More than half of $50 million is going to hospitals that are owned by large, financially resilient nonprofit hospital systems with substantial investment portfolios and net worths.
The nation's top infectious disease expert says If a monitoring board gave the green light, vaccine manufacturers would be obligated to end their trials early and make the shots available.
Sep 2, 2020
Image
Brothers Cannabis located in Southeast Portland has remained open during the pandemic/Mark Graves/The Oregonian/OregonLive